Olutasidenib
Product Specifications
CAS Number
1887014-12-1
Target
Isocitrate Dehydrogenase (IDH) |||Dehydrogenase
Related Pathways
Metabolism
Purity
0.9959
Bioactivity
Olutasidenib (FT-2102) is under the study in the treatment of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) . Olutasidenib is a highly effective, brain penetrant, and selective inhibitor of the mutant Isocitrate dehydrogenase 1 (IDH1) (IC50: 21.2 nM and 114 nM for IDH1- R132H and IDH1- R132C, respectively) .
Smiles
C[C@H](Nc1ccc(C#N)n(C)c1=O)c1cc2cc(Cl)ccc2[nH]c1=O
Molecular Formula
C18H15ClN4O2
Molecular Weight
354.79
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
032159-PE 200 µL
ATF2, phosphorylated (pS480) (Cyclic AMP-dependent transcription factor ATF-2, Activating transcription factor 2, cAMP response element-binding protein CRE-BP1, HB16, CREB2, CREBP1) (PE) discontinued
Ask
View Details 
MBS1430881-01 0.02 mg (E-Coli)
Recombinant Streptococcus pneumoniae Uncharacterized protein SP_1052 (SP_1052)
Ask
View Details MBS1430881-02 0.02 mg (Yeast)
Recombinant Streptococcus pneumoniae Uncharacterized protein SP_1052 (SP_1052)
Ask
View Details 
MBS1430881-03 0.1 mg (E-Coli)
Recombinant Streptococcus pneumoniae Uncharacterized protein SP_1052 (SP_1052)
Ask
View Details